NCT00241904View on ClinicalTrials.gov

Reducing Total Cardiovascular Risk in an Urban Community

PHASE4CompletedINTERVENTIONAL
Enrollment

525

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Cardiovascular DiseasesHeart DiseasesCoronary DiseaseDiabetes MellitusAtherosclerosisCerebral ArteriosclerosisHypertension
Interventions
BEHAVIORAL

Lifestyle Changes

Nutrition counseling, smoking cessation counseling, medication compliance counseling, exercise

DRUG

Antiplatelet Agents

Aspirin 81 mg q day

DRUG

Beta Blocker

Oral medication

DRUG

ACE Inhibitors

Oral medications, received 1-2 times per day

Trial Locations (1)

21205

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Johns Hopkins University

OTHER

NCT00241904 - Reducing Total Cardiovascular Risk in an Urban Community | Biotech Hunter | Biotech Hunter